Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
Academic Article
Publication Date:
2022
Short description:
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients / Barbanti, P., Egeo, G., Aurilia, C., Altamura, C., D'Onofrio, F., Finocchi, C., Albanese, M., Aguggia, M., Rao, R., Zucco, M., Frediani, F., Filippi, M., Messina, R., Cevoli, S., Carnevale, A., Fiorentini, G., Messina, S., Bono, F., Torelli, P., Proietti, S., et al.. - In: THE JOURNAL OF HEADACHE AND PAIN. - ISSN 1129-2369. - 23:1(2022), pp. 1-12. [10.1186/s10194-022-01498-6]
abstract:
The identification of predictors of response to antiCGRP mAbs could favor tailored therapies and personalized treatment plans. This study is aimed at investigating predictors of ≥ 50%, ≥ 75% and 100% response at 24 weeks in patients with high-frequency episodic (HFEM: 8-14 days/month) or chronic migraine (CM).
Iris type:
1.1 Articolo in rivista
List of contributors:
Barbanti, Piero; Egeo, Gabriella; Aurilia, Cinzia; Altamura, Claudia; D'Onofrio, Florindo; Finocchi, Cinzia; Albanese, Maria; Aguggia, Marco; Rao, Renata; Zucco, Maurizio; Frediani, Fabio; Filippi, Massimo; Messina, Roberta; Cevoli, Sabina; Carnevale, Antonio; Fiorentini, Giulia; Messina, Stefano; Bono, Francesco; Torelli, Paola; Proietti, Stefania; Bonassi, Stefano; Vernieri, Fabrizio
Full Text:
Published in: